N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide

C53H72F2N10O5 — CID 155347228

IUPACN-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide
SMILESCc1cnc(CC(=O)NC2CCC(F)(CCN3CCc4nc(OC5CCC5)cc(C5CN(CCC6(F)CCC(NC(=O)Cc7cnn(C)n7)CC6)CCc6ccc(OC7CCC7)nc65)c4CC3)CC2)o1
InChIInChI=1S/C53H72F2N10O5/c1-35-32-56-49(68-35)31-47(67)59-38-13-18-52(54,19-14-38)22-27-64-25-16-42-43(30-50(60-45(42)17-26-64)70-41-7-4-8-41)44-34-65(24-15-36-9-10-48(61-51(36)44)69-40-5-3-6-40)28-23-53(55)20-11-37(12-21-53)58-46(66)29-39-33-57-63(2)62-39/h9-10,30,32-33,37-38,40-41,44H,3-8,11-29,31,34H2,1-2H3,(H,58,66)(H,59,67)
InChIKeyQTNOUHONFLGXIS-UHFFFAOYSA-N
MW967.22 g/mol
LogP6.95
Rot. Bonds17

About N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide

N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide (PubChem CID 155347228) has the molecular formula C53H72F2N10O5 and a molecular weight of 967.22 g/mol. Its IUPAC name is N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide.

Molecular Properties

Compound NameN-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide
PubChem CID155347228
Molecular FormulaC53H72F2N10O5
Molecular Weight967.22 g/mol
Exact Mass966.57
IUPAC NameN-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide
SMILESCc1cnc(CC(=O)NC2CCC(F)(CCN3CCc4nc(OC5CCC5)cc(C5CN(CCC6(F)CCC(NC(=O)Cc7cnn(C)n7)CC6)CCc6ccc(OC7CCC7)nc65)c4CC3)CC2)o1
InChIInChI=1S/C53H72F2N10O5/c1-35-32-56-49(68-35)31-47(67)59-38-13-18-52(54,19-14-38)22-27-64-25-16-42-43(30-50(60-45(42)17-26-64)70-41-7-4-8-41)44-34-65(24-15-36-9-10-48(61-51(36)44)69-40-5-3-6-40)28-23-53(55)20-11-37(12-21-53)58-46(66)29-39-33-57-63(2)62-39/h9-10,30,32-33,37-38,40-41,44H,3-8,11-29,31,34H2,1-2H3,(H,58,66)(H,59,67)
InChIKeyQTNOUHONFLGXIS-UHFFFAOYSA-N
XLogP6.95
TPSA165.66 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds17
Heavy Atoms70
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500967.22
LogP ≤ 56.95
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Analyze N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide?
The IUPAC name of N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide (CID 155347228) is N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide.
What is the SMILES notation for N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide?
The canonical SMILES for N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide is Cc1cnc(CC(=O)NC2CCC(F)(CCN3CCc4nc(OC5CCC5)cc(C5CN(CCC6(F)CCC(NC(=O)Cc7cnn(C)n7)CC6)CCc6ccc(OC7CCC7)nc65)c4CC3)CC2)o1.
What is the InChIKey of N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide?
The InChIKey is QTNOUHONFLGXIS-UHFFFAOYSA-N. The full InChI is InChI=1S/C53H72F2N10O5/c1-35-32-56-49(68-35)31-47(67)59-38-13-18-52(54,19-14-38)22-27-64-25-16-42-43(30-50(60-45(42)17-26-64)70-41-7-4-8-41)44-34-65(24-15-36-9-10-48(61-51(36)44)69-40-5-3-6-40)28-23-53(55)20-11-37(12-21-53)58-46(66)29-39-33-57-63(2)62-39/h9-10,30,32-33,37-38,40-41,44H,3-8,11-29,31,34H2,1-2H3,(H,58,66)(H,59,67).
What are the key properties of N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide?
N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide has a molecular weight of 967.22 g/mol, XLogP of 6.95, 17 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[2-[2-cyclobutyloxy-9-[2-cyclobutyloxy-7-[2-[1-fluoro-4-[[2-(5-methyl-1,3-oxazol-2-yl)acetyl]amino]cyclohexyl]ethyl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-4-yl]-5,6,8,9-tetrahydropyrido[2,3-d]azepin-7-yl]ethyl]-4-fluorocyclohexyl]-2-(2-methyltriazol-4-yl)acetamide is sourced from PubChem (CID 155347228), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).